{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:51:23Z","timestamp":1791154283974,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,4,28]],"date-time":"2014-04-28T00:00:00Z","timestamp":1398643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,4,28]],"date-time":"2014-04-28T00:00:00Z","timestamp":1398643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1038\/bmt.2014.75","type":"journal-article","created":{"date-parts":[[2014,4,28]],"date-time":"2014-04-28T13:41:57Z","timestamp":1398692517000},"page":"972-976","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Complement component C3 mediates Th1\/Th17 polarization in human T-cell activation and cutaneous GVHD"],"prefix":"10.1038","volume":"49","author":[{"given":"Q","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Carre\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Patenia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K Y","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Xydes-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A M","family":"Alousi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R E","family":"Champlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G E","family":"Sale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Afshar-Kharghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,28]]},"reference":[{"key":"BFbmt201475_CR1","first-page":"353","volume-title":"Thomas\u2019s Hematopoietic Cell Transplantation","author":"R Korngold","year":"2004","unstructured":"Korngold R Friedman TM . Murine models for graft-versus-host disease. In: Blume KG, Forman SJ, Appelbaum FR (eds). Thomas\u2019s Hematopoietic Cell Transplantation, 3rd edn. Blackwell Publishing: Malden, MA, USA, 2004; pp 353\u2013368."},{"key":"BFbmt201475_CR2","first-page":"286","volume-title":"Thomas\u2019s Hematopoietic Cell Transplantation","author":"GE Sale","year":"2004","unstructured":"Sale GE Shulman HM Hackman RC . Pathology of hematopoietic cell transplantation. In: Blume KG, Forman SJ, Appelbaum FR (eds). Thomas\u2019s Hematopoietic Cell Transplantation, 3rd edn. Blackwell Publishing Ltd: Malden, MA, USA, 2004; pp 286\u2013299."},{"key":"BFbmt201475_CR3","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nri2000","volume":"7","author":"WD Shlomchik","year":"2007","unstructured":"Shlomchik WD . Graft-versus-host disease. Nat Rev Immunol 2007; 7: 340\u2013352.","journal-title":"Nat Rev Immunol"},{"key":"BFbmt201475_CR4","first-page":"1","volume-title":"Graft-vs-Host-Disease","author":"JLM Ferrara","year":"2005","unstructured":"Ferrara JLM, Cooke KR, Teshima T . The Pathophysiology of graft-vs-host disease. In: Ferrara JLM, Cooke KR, Deeg HJ (eds). Graft-vs-Host-Disease, 3rd edn. Marcel Dekker: New York, NY, USA, 2005; pp 1\u201334."},{"key":"BFbmt201475_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nri1994","volume":"7","author":"C Kemper","year":"2007","unstructured":"Kemper C, Atkinson JP . T-cell regulation: with complements from innate immunity. Nat Rev Immunol 2007; 7: 9\u201318.","journal-title":"Nat Rev Immunol"},{"key":"BFbmt201475_CR6","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.imbio.2011.06.004","volume":"217","author":"PS Heeger","year":"2012","unstructured":"Heeger PS, Kemper C . Novel roles of complement in T effector cell regulation. Immunobiology 2012; 217: 216\u2013224.","journal-title":"Immunobiology"},{"key":"BFbmt201475_CR7","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nm0602-582","volume":"8","author":"JR Pratt","year":"2002","unstructured":"Pratt JR, Basheer SA, Sacks SH . Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med 2002; 8: 582\u2013587.","journal-title":"Nat Med"},{"key":"BFbmt201475_CR8","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.coi.2007.07.007","volume":"19","author":"W Zhou","year":"2007","unstructured":"Zhou W, Medof ME, Heeger PS, Sacks S . Graft-derived complement as a mediator of transplant injury. Curr Opin Immunol 2007; 19: 569\u2013576.","journal-title":"Curr Opin Immunol"},{"key":"BFbmt201475_CR9","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.bbmt.2012.05.014","volume":"18","author":"Q Ma","year":"2012","unstructured":"Ma Q, Li D, Nurieva R, Patenia R, Bassett R, Cao W et al. Reduced GVHD in C3-deficient mice is associated with the decrease of donor Th1\/Th17 differentiation. Biol Blood Marrow Transplant 2012; 18: 1174\u20131181.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201475_CR10","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1172\/JCI61019","volume":"122","author":"WH Kwan","year":"2012","unstructured":"Kwan WH, Hashimoto D, Paz-Artal E, Ostrow K, Greter M, Raedler H et al. Antigen-presenting cell-derived complement modulates graft-versus-host disease. J Clin Invest 2012; 122: 2234\u20132238.","journal-title":"J Clin Invest"},{"key":"BFbmt201475_CR11","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1182\/blood-2010-12-290403","volume":"117","author":"JM Coghill","year":"2011","unstructured":"Coghill JM, Sarantopoulos S, Moran TP, Murphy WJ, Blazar BR, Serody JS . Effector CD4 + T cells, the cytokines they generate, and GVHD: something old and something new. Blood 2011; 117: 3268\u20133276.","journal-title":"Blood"},{"key":"BFbmt201475_CR12","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.yexmp.2005.03.007","volume":"79","author":"F Niculescu","year":"2005","unstructured":"Niculescu F, Niculescu T, Nguyen P, Puliaev R, Papadimitriou JC, Gaspari A et al. Both apoptosis and complement membrane attack complex deposition are major features of murine acute graft-vs-host disease. Exp Mol Pathol 2005; 79: 136\u2013145.","journal-title":"Exp Mol Pathol"},{"key":"BFbmt201475_CR13","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.4049\/jimmunol.120.5.1485","volume":"120","author":"MS Tsoi","year":"1978","unstructured":"Tsoi MS, Storb R, Jones E, Weiden PL, Shulman H, Witherspoon R et al. Deposition of IgM and complement at the dermoepidermal junction in acute and chronic cutaneous graft-vs-host disease in man. J Immunol 1978; 120: 1485\u20131492.","journal-title":"J Immunol"},{"key":"BFbmt201475_CR14","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.1182\/blood-2011-04-350249","volume":"118","author":"KJ Martires","year":"2011","unstructured":"Martires KJ, Baird K, Steinberg SM, Grkovic L, Joe GO, Williams KM et al. Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease. Blood 2011; 118: 4250\u20134257.","journal-title":"Blood"},{"key":"BFbmt201475_CR15","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/pro.5560070311","volume":"7","author":"D Morikis","year":"1998","unstructured":"Morikis D, Assa-Munt N, Sahu A, Lambris JD . Solution structure of Compstatin, a potent complement inhibitor. Protein Sci 1998; 7: 619\u2013627.","journal-title":"Protein Sci"},{"key":"BFbmt201475_CR16","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1182\/blood.V92.5.1661","volume":"92","author":"B Nilsson","year":"1998","unstructured":"Nilsson B, Larsson R, Hong J, Elgue G, Ekdahl KN, Sahu A et al. Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal circulation. Blood 1998; 92: 1661\u20131667.","journal-title":"Blood"},{"key":"BFbmt201475_CR17","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1097\/CJI.0b013e3181fb0486","volume":"33","author":"D Li","year":"2010","unstructured":"Li D, Li Y, Hernandez JA, Patenia R, Kim TK, Khalili J et al. Lovastatin inhibits T-cell proliferation while preserving the cytolytic function of EBV, CMV, and MART-1-specific CTLs. J Immunother 2010; 33: 975\u2013982.","journal-title":"J Immunother"},{"key":"BFbmt201475_CR18","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.bbmt.2009.12.002","volume":"16","author":"LA Palmer","year":"2010","unstructured":"Palmer LA, Sale GE, Balogun JI, Li D, Jones D, Molldrem JJ et al. Chemokine receptor CCR5 mediates alloimmune responses in graft-versus-host disease. Biol Blood Marrow Transplant 2010; 16: 311\u2013319.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201475_CR19","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1084\/jem.186.9.1407","volume":"186","author":"D Hamann","year":"1997","unstructured":"Hamann D, Baars PA, Rep MH, Hooibrink B, Kerkhof-Garde SR, Klein MR et al. Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med 1997; 186: 1407\u20131418.","journal-title":"J Exp Med"},{"key":"BFbmt201475_CR20","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/44385","volume":"401","author":"F Sallusto","year":"1999","unstructured":"Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A . Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401: 708\u2013712.","journal-title":"Nature"},{"key":"BFbmt201475_CR21","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1002\/1521-4141(200007)30:7<1823::AID-IMMU1823>3.0.CO;2-6","volume":"30","author":"L Tussey","year":"2000","unstructured":"Tussey L, Speller S, Gallimore A, Vessey R . Functionally distinct CD8 + memory T cell subsets in persistent EBV infection are differentiated by migratory receptor expression. Eur J Immunol 2000; 30: 1823\u20131829.","journal-title":"Eur J Immunol"},{"key":"BFbmt201475_CR22","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/j.1600-0625.2011.01295.x","volume":"20","author":"R Purwar","year":"2011","unstructured":"Purwar R, B\u00e4umer W, Niebuhr M, Tschernig T, Kietzmann M, Werfel T . A protective role of complement component 3 in T cell-mediated skin inflammation. Exp Dermatol 2011; 20: 709\u2013714.","journal-title":"Exp Dermatol"},{"key":"BFbmt201475_CR23","doi-asserted-by":"publisher","first-page":"4327","DOI":"10.1182\/blood-2009-06-204669","volume":"114","author":"G Soci\u00e9","year":"2009","unstructured":"Soci\u00e9 G, Blazar BR . Acute graft-versus-host disease: from the bench to the bedside. Blood 2009; 114: 4327\u20134336.","journal-title":"Blood"},{"key":"BFbmt201475_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1172\/JCI17601","volume":"112","author":"BE Anderson","year":"2003","unstructured":"Anderson BE, McNiff J, Yan J, Doyle H, Mamula M, Shlomchik MJ et al. Memory CD4+ T cells do not induce graft-versus-host disease. J Clin Invest 2003; 112: 101\u2013108.","journal-title":"J Clin Invest"},{"key":"BFbmt201475_CR25","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1182\/blood-2003-08-2987","volume":"103","author":"BJ Chen","year":"2004","unstructured":"Chen BJ, Cui X, Sempowski GD, Liu C, Chao NJ . Transfer of allogeneic CD62L\u2212 memory T cells without graft-versus-host disease. Blood 2004; 103: 1534\u20131541.","journal-title":"Blood"},{"key":"BFbmt201475_CR26","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.1182\/blood-2003-09-3135","volume":"103","author":"Y Zhang","year":"2004","unstructured":"Zhang Y, Joe G, Zhu J, Carroll R, Levine B, Hexner E et al. Dendritic cell-activated CD44hiCD8+ T cells are defective in mediating acute graft-versus-host disease but retain graft-versus-leukemia activity. Blood 2004; 103: 3970\u20133978.","journal-title":"Blood"},{"key":"BFbmt201475_CR27","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1016\/j.molimm.2007.10.031","volume":"45","author":"ES Reis","year":"2008","unstructured":"Reis ES, Barbuto JA, Kohl J, Isaac L . Impaired dendritic cell differentiation and maturation in the absence of C3. Mol Immunol 2008; 45: 1952\u20131962.","journal-title":"Mol Immunol"},{"key":"BFbmt201475_CR28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1189\/jlb.69.1.69","volume":"69","author":"K Kerekes","year":"2001","unstructured":"Kerekes K, Cooper PD, Prechl J, J\u00f3zsi M, Bajtay Z, Erdei A . Adjuvant effect of gamma-inulin is mediated by C3 fragments deposited on antigen-presenting cells. J Leukoc Biol 2001; 69: 69\u201374.","journal-title":"J Leukoc Biol"},{"key":"BFbmt201475_CR29","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.4049\/jimmunol.176.6.3330","volume":"176","author":"Q Peng","year":"2006","unstructured":"Peng Q, Li K, Patel H, Sacks SH, Zhou W . Dendritic cell synthesis of C3 is required for full T cell activation and development of a Th1 phenotype. J Immunol 2006; 176: 3330\u20133341.","journal-title":"J Immunol"},{"key":"BFbmt201475_CR30","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1016\/j.molimm.2011.04.014","volume":"48","author":"TM Woodruff","year":"2001","unstructured":"Woodruff TM, Nandakumar KS, Tedesco F . Inhibiting the C5-C5a receptor axis. Mol Immunol 2001; 48: 1631\u20131642.","journal-title":"Mol Immunol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt201475.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt201475","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt201475.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T12:41:17Z","timestamp":1689165677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt201475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,28]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["BFbmt201475"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2014.75","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,28]]},"assertion":[{"value":"2 November 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}